Organo (6368.T) Stock Price

Organo Price

JPX·CLOSED
14,555.00JPY-230.00 (-1.57 %)
Market closed

Revenue has compounded at 4.1% per year over the past 19 years to 163.27 B JPY. Earnings per share have grown at 6.2% per year over the last 19 years. Organo's net margin stands at 14.8%, up from 7.0% several years earlier. Organo currently offers a dividend yield of about 1.26%. The payout ratio is around 35% of earnings. The dividend has grown at 15.5% per year over the past 19 years. Analysts set a median price target of 15,504.00 JPY, implying 6.5% above the current price. Of 8 analysts, 7 rate the stock a buy — an overall Buy consensus. The stock trades about 35% above its 52-week low.

Organo stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Organo over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Organo stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Organo's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Organo Stock Price History
DateOrgano Price
8/7/202614,555.00 JPY
8/6/202614,785.00 JPY
8/5/202615,315.00 JPY
8/4/202614,350.00 JPY
8/3/202614,530.00 JPY
7/31/202614,815.00 JPY
7/30/202613,485.00 JPY
7/29/202612,740.00 JPY
7/28/202613,535.00 JPY
7/27/202614,995.00 JPY
7/24/202615,140.00 JPY
7/23/202615,565.00 JPY
7/22/202615,310.00 JPY
7/21/202615,115.00 JPY
7/17/202614,385.00 JPY
7/16/202615,585.00 JPY
7/15/202615,705.00 JPY
7/14/202614,895.00 JPY
7/13/202615,670.00 JPY
7/10/202616,000.00 JPY
7/9/202615,455.00 JPY
7/8/202615,235.00 JPY
7/7/202615,250.00 JPY
7/6/202615,610.00 JPY
7/3/202616,020.00 JPY
7/2/202616,240.00 JPY
7/1/202617,155.00 JPY
6/30/202616,330.00 JPY
6/29/202615,920.00 JPY
6/26/202616,385.00 JPY
6/25/202617,340.00 JPY
6/24/202616,490.00 JPY
6/23/202616,825.00 JPY
6/22/202617,725.00 JPY
6/19/202617,765.00 JPY
6/18/202618,445.00 JPY
6/17/202616,585.00 JPY
6/16/202616,085.00 JPY
6/15/202616,100.00 JPY
6/12/202614,990.00 JPY
6/11/202613,905.00 JPY
6/10/202614,375.00 JPY
6/9/202615,005.00 JPY
6/8/202615,015.00 JPY
6/5/202615,420.00 JPY
6/4/202615,915.00 JPY
6/3/202615,640.00 JPY
6/2/202615,195.00 JPY
6/1/202615,680.00 JPY
5/29/202615,855.00 JPY
5/28/202616,155.00 JPY
5/27/202616,450.00 JPY
5/26/202616,570.00 JPY
5/25/202616,700.00 JPY
5/22/202616,630.00 JPY
5/21/202616,680.00 JPY
5/20/202616,100.00 JPY
5/19/202616,410.00 JPY
5/18/202617,195.00 JPY
5/15/202618,960.00 JPY
5/14/202619,280.00 JPY
5/13/202618,645.00 JPY
5/12/202618,310.00 JPY
5/11/202618,025.00 JPY
5/8/202617,735.00 JPY
5/7/202616,830.00 JPY
5/1/202615,560.00 JPY
4/30/202615,780.00 JPY
4/28/202616,300.00 JPY
4/27/202616,300.00 JPY
4/24/202615,860.00 JPY
4/23/202615,925.00 JPY
4/22/202615,825.00 JPY
4/21/202615,410.00 JPY
4/20/202615,445.00 JPY
4/17/202615,815.00 JPY
4/16/202615,550.00 JPY
4/15/202615,405.00 JPY
4/14/202615,960.00 JPY
4/13/202615,990.00 JPY
4/10/202616,195.00 JPY
4/9/202615,895.00 JPY
4/8/202615,955.00 JPY
4/7/202614,475.00 JPY
4/6/202614,510.00 JPY
4/3/202614,425.00 JPY
4/2/202614,405.00 JPY
4/1/202614,870.00 JPY
3/31/202613,610.00 JPY
3/30/202614,040.00 JPY
3/27/202614,855.00 JPY
3/26/202614,930.00 JPY
3/25/202614,630.00 JPY
3/24/202613,970.00 JPY
3/23/202613,490.00 JPY
3/19/202614,635.00 JPY
3/18/202615,205.00 JPY
3/17/202614,660.00 JPY
3/16/202614,750.00 JPY
3/13/202615,140.00 JPY
3/12/202615,230.00 JPY
3/11/202615,600.00 JPY
3/10/202615,340.00 JPY
3/9/202614,650.00 JPY
3/6/202615,980.00 JPY
3/5/202616,275.00 JPY
3/4/202615,510.00 JPY
3/3/202617,150.00 JPY
3/2/202617,550.00 JPY
2/27/202617,350.00 JPY
2/26/202617,010.00 JPY
2/25/202617,095.00 JPY
2/24/202616,885.00 JPY
2/20/202616,620.00 JPY
2/19/202616,550.00 JPY
2/18/202616,165.00 JPY
2/17/202615,365.00 JPY
2/16/202615,650.00 JPY
2/13/202615,635.00 JPY
2/12/202615,280.00 JPY
2/10/202614,510.00 JPY
2/9/202614,330.00 JPY
2/6/202614,245.00 JPY
2/5/202614,740.00 JPY
2/4/202616,390.00 JPY
2/3/202616,700.00 JPY
2/2/202615,950.00 JPY
1/30/202616,230.00 JPY
1/29/202616,410.00 JPY
1/28/202616,100.00 JPY
1/27/202616,285.00 JPY
1/26/202615,775.00 JPY
1/23/202616,400.00 JPY
1/22/202616,300.00 JPY
1/21/202616,000.00 JPY
1/20/202615,695.00 JPY
1/19/202616,230.00 JPY
1/16/202616,530.00 JPY
1/15/202615,390.00 JPY
1/14/202615,080.00 JPY
1/13/202614,530.00 JPY
1/9/202613,945.00 JPY
1/8/202613,955.00 JPY
1/7/202614,415.00 JPY
1/6/202613,810.00 JPY
1/5/202613,615.00 JPY
12/30/202512,955.00 JPY
12/29/202513,085.00 JPY
12/26/202512,960.00 JPY
12/25/202513,050.00 JPY
12/24/202512,905.00 JPY
12/23/202512,860.00 JPY
12/22/202512,900.00 JPY
12/19/202512,240.00 JPY
12/18/202512,145.00 JPY
12/17/202512,225.00 JPY
12/16/202512,340.00 JPY
12/15/202512,670.00 JPY
12/12/202513,100.00 JPY
12/11/202513,120.00 JPY
12/10/202513,345.00 JPY
12/9/202513,665.00 JPY
12/8/202513,525.00 JPY
12/5/202513,280.00 JPY
12/4/202512,985.00 JPY
12/3/202513,180.00 JPY
12/2/202512,750.00 JPY
12/1/202512,945.00 JPY
11/28/202513,350.00 JPY
11/27/202513,120.00 JPY
11/26/202512,925.00 JPY
11/25/202512,540.00 JPY
11/21/202512,585.00 JPY
11/20/202513,215.00 JPY
11/19/202512,710.00 JPY
11/18/202512,980.00 JPY
11/17/202514,380.00 JPY
11/14/202513,970.00 JPY
11/13/202514,350.00 JPY
11/12/202514,125.00 JPY
11/11/202513,770.00 JPY
11/10/202514,000.00 JPY
11/7/202513,180.00 JPY
11/6/202513,045.00 JPY
11/5/202512,955.00 JPY
11/4/202513,795.00 JPY
10/31/202513,280.00 JPY
10/30/202512,770.00 JPY
10/29/202512,940.00 JPY
10/28/202512,660.00 JPY
10/27/202512,780.00 JPY
10/24/202512,560.00 JPY
10/23/202512,520.00 JPY
10/22/202512,370.00 JPY
10/21/202512,230.00 JPY
10/20/202512,260.00 JPY
10/17/202511,790.00 JPY
10/16/202512,140.00 JPY
10/15/202511,990.00 JPY
10/14/202511,380.00 JPY
10/10/202512,000.00 JPY
10/9/202511,810.00 JPY
10/8/202511,750.00 JPY
10/7/202511,690.00 JPY
10/6/202511,620.00 JPY
10/3/202511,140.00 JPY
10/2/202511,070.00 JPY
10/1/202511,090.00 JPY
9/30/202511,340.00 JPY
9/29/202511,300.00 JPY
9/26/202511,410.00 JPY
9/25/202511,710.00 JPY
9/24/202511,710.00 JPY
9/22/202511,990.00 JPY
9/19/202511,910.00 JPY
9/18/202512,120.00 JPY
9/17/202512,000.00 JPY
9/16/202512,330.00 JPY
9/12/202512,250.00 JPY
9/11/202512,460.00 JPY
9/10/202512,030.00 JPY
9/9/202511,780.00 JPY
9/8/202511,820.00 JPY
9/5/202511,630.00 JPY
9/4/202511,030.00 JPY
9/3/202510,820.00 JPY
9/2/202510,990.00 JPY
9/1/202510,960.00 JPY
8/29/202511,270.00 JPY
8/28/202511,220.00 JPY
8/27/202511,220.00 JPY
8/26/202511,240.00 JPY
8/25/202511,210.00 JPY
8/22/202511,270.00 JPY
8/21/202511,400.00 JPY
8/20/202511,360.00 JPY
8/19/202511,700.00 JPY
8/18/202511,800.00 JPY
8/15/202511,990.00 JPY
8/14/202511,920.00 JPY
8/13/202512,040.00 JPY
8/12/202511,780.00 JPY
Access this data via the Eulerpool API
Get Free API Key

Organo Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
112.07 B JPY
10.85 B JPY
9.21 B JPY
Jan 1, 2023
132.43 B JPY
15.21 B JPY
11.73 B JPY
Jan 1, 2024
150.36 B JPY
22.54 B JPY
17.31 B JPY
Jan 1, 2025
163.27 B JPY
31.12 B JPY
24.15 B JPY
Jan 1, 2026 (e)
175.92 B JPY
59.72 B JPY
27.63 B JPY
Jan 1, 2027 (e)
203.10 B JPY
68.94 B JPY
31.19 B JPY
Jan 1, 2028 (e)
221.43 B JPY
75.17 B JPY
34.44 B JPY
Jan 1, 2029 (e)
231.33 B JPY
78.53 B JPY
36.76 B JPY

Organo Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 2:12 AM
 
REVENUEB JPY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB JPY
EBITB JPY
EBIT MARGIN%
NET INCOMEB JPY
NET INCOME GROWTH%
DIV.JPY
DIV. GROWTH%
SHARESM
2014201520162017201820192020202120222023202420252026e2027e2028e2029e
62.1068.7478.7281.1179.2392.2796.52100.64112.07132.43150.36163.27175.92203.10221.43231.33
-6.9310.7014.523.04-2.3316.474.604.2711.3618.1613.548.597.7515.459.024.47
23.4422.6122.5522.9824.1724.8428.2726.1625.4426.4129.1633.8033.8033.8033.8033.80
14.5515.5417.7518.6419.1522.9227.2826.3328.5134.9843.8455.1859.4668.6474.8478.19
0.832.403.954.113.826.569.919.5810.8515.2122.5431.1259.7268.9475.1778.53
1.343.495.015.074.827.1110.279.529.6811.4914.9919.0633.9533.9533.9533.95
0.661.092.492.732.784.457.167.079.2111.7317.3124.1527.6331.1934.4436.76
-74.1063.40129.039.901.7960.1460.87-1.2330.2027.3647.5739.5114.4212.8710.426.72
8.008.0010.0030.0057.0091.00109.00134.00117.0074.00132.00184.00289.00346.80416.16–
-20.00–25.00200.0090.0059.6519.7822.94-12.69-36.7578.3839.3957.0720.0020.00–
12.0011.5211.5246.0646.0545.8445.7645.8845.9045.8645.9345.9745.9745.9745.9745.97
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Organo generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Organo retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Organo's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Organo has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Organo's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Organo stock margins

The Organo margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Organo. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Organo.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
26.16 %
9.52 %
7.03 %
Jan 1, 2022
25.44 %
9.68 %
8.22 %
Jan 1, 2023
26.41 %
11.49 %
8.86 %
Jan 1, 2024
29.16 %
14.99 %
11.51 %
Jan 1, 2025
33.80 %
19.06 %
14.79 %
Jan 1, 2026 (e)
33.80 %
33.95 %
15.71 %
Jan 1, 2027 (e)
33.80 %
33.95 %
15.36 %
Jan 1, 2028 (e)
33.80 %
33.95 %
15.55 %

Organo Stock Revenue, EBIT, Earnings per Share

The Organo earnings per share therefore indicates how much revenue Organo has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
2,193.50 JPY
208.78 JPY
154.18 JPY
Jan 1, 2022
2,441.80 JPY
236.40 JPY
200.67 JPY
Jan 1, 2023
2,887.43 JPY
331.68 JPY
255.76 JPY
Jan 1, 2024
3,273.95 JPY
490.89 JPY
376.92 JPY
Jan 1, 2025
3,551.78 JPY
676.99 JPY
525.36 JPY
Jan 1, 2026 (e)
3,826.99 JPY
1,299.12 JPY
601.15 JPY
Jan 1, 2027 (e)
4,418.27 JPY
1,499.84 JPY
678.52 JPY
Jan 1, 2028 (e)
4,816.92 JPY
1,635.16 JPY
749.20 JPY

Organo business model & stock analysis

Organo Corp is an internationally operating company specialized in the production and distribution of products in the health and wellness industry. The company was founded in Vancouver, Canada in 2008 by Bernardo Chua. Organo Corp's business model is based on network marketing to sell its products. This has allowed the company to quickly build a large customer base and become active in over 50 countries. The goal of Organo Corp is to help every customer lead a healthier and happier life. Organo Corp is divided into different divisions to offer customers a wide range of products. One of the main divisions is "Organo Gold," which offers coffee and tea products. These products are based on traditional Asian herbs and fungi such as Reishi, Ganoderma, and Cordyceps. These herbs have many active ingredients that strengthen the immune system, increase energy levels, reduce stress, and promote overall well-being. Another division of Organo Corp is "Organo Essentials," which offers products for a healthy everyday life. This includes supplements such as multivitamin tablets, protein powder, and Omega-3 fatty acids. These supplements are made from high-quality ingredients and aim to improve overall well-being. Organo Corp also has a "Personal Care" division, which offers products for personal hygiene. These include soaps, shampoos, creams, and lotions. These products contain natural ingredients such as tea tree oil, aloe vera, shea butter, and various essential oils that are intended to nourish and protect the skin. The company also has an "Organo Graphics" division, which offers marketing materials to help independent distributors of Organo Corp build their own business. This includes brochures, business cards, and sales tools. Organo Corp has also made a name for itself through various philanthropic activities. The company has established the "OG Care Foundation," which advocates for disadvantaged children and their families worldwide. The foundation supports projects in the areas of education, health, and well-being. In summary, Organo Corp is a company specializing in the sale of products in the health and wellness industry. The company offers a wide range of products based on natural ingredients such as Asian herbs and fungi. Through network marketing, Organo Corp has quickly built a large customer base and is now active in over 50 countries. Additionally, the company is committed to supporting disadvantaged children around the world through the "OG Care Foundation."

Organo SWOT Analysis

Strengths

Organo Corp possesses several key strengths:

  • Strong brand presence and reputation in the market
  • Diverse product portfolio catering to different customer segments
  • Robust distribution network and partnerships
  • Innovative research and development capabilities
  • Efficient supply chain management

Despite its strengths, Organo Corp has certain weaknesses:

  • Limited international presence
  • High reliance on a few key suppliers
  • Slower adoption of digital technologies
  • Dependency on specific market segments
  • Average customer service compared to competitors

Organo Corp can take advantage of the following opportunities:

  • Expanding into new emerging markets
  • Investing in research and development for new products
  • Acquiring or partnering with complementary businesses
  • Improving online presence and e-commerce capabilities
  • Capitalizing on growing demand for sustainable products

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Weaknesses

Despite its strengths, Organo Corp has certain weaknesses:

  • Limited international presence
  • High reliance on a few key suppliers
  • Slower adoption of digital technologies
  • Dependency on specific market segments
  • Average customer service compared to competitors

Organo Corp can take advantage of the following opportunities:

  • Expanding into new emerging markets
  • Investing in research and development for new products
  • Acquiring or partnering with complementary businesses
  • Improving online presence and e-commerce capabilities
  • Capitalizing on growing demand for sustainable products

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Opportunities

Organo Corp can take advantage of the following opportunities:

  • Expanding into new emerging markets
  • Investing in research and development for new products
  • Acquiring or partnering with complementary businesses
  • Improving online presence and e-commerce capabilities
  • Capitalizing on growing demand for sustainable products

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Threats

Organo Corp should be cautious of the following threats:

  • Intense competition in the industry
  • Changing consumer preferences and trends
  • Inflation and fluctuating raw material prices
  • Government regulations and compliance requirements
  • Economic downturns and market uncertainties

Organo Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Organo historical P/E ratio, EBIT multiple, and P/S ratio

Organo annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Organo shares outstanding

The number of shares of Organo was 45.97 M in 2025. This indicates how many shares Organo is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
45.88 M Stocks
Jan 1, 2022
45.90 M Stocks
Jan 1, 2023
45.86 M Stocks
Jan 1, 2024
45.93 M Stocks
Jan 1, 2025
45.97 M Stocks
Jan 1, 2026 (e)
45.97 M Stocks
Jan 1, 2027 (e)
45.97 M Stocks
Jan 1, 2028 (e)
45.97 M Stocks

Organo stock splits

In Organo's history, there have been no stock splits.

Organo Dividend History

37 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
202695.00JPYYTD—1×
Mar 30, 202695.00JPY 0.0%1/1
2025184.00JPY↑ 39.4%2×
Mar 28, 202589.00JPY↑ 25.4%1/2
Sep 29, 202595.00JPY↑ 6.7%2/2
2024132.00JPY↑ 78.4%2×
202374.00JPY↓ 36.8%2×
2022117.00JPY↓ 12.7%2×
2021134.00JPY↑ 22.9%2×
2020109.00JPY↑ 19.8%2×
201991.00JPY↑ 59.6%2×
201857.00JPY↑ 90.0%2×
201730.00JPY↑ 200.0%2×

Organo dividend history and estimates

In 2025, Organo paid a dividend amounting to 184.00 JPY. Dividend means that Organo distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2021
134.00 JPY
0.00 JPY
Jan 1, 2022
117.00 JPY
0.00 JPY
Jan 1, 2023
74.00 JPY
0.00 JPY
Jan 1, 2024
132.00 JPY
0.00 JPY
Jan 1, 2025
184.00 JPY
0.00 JPY
Jan 1, 2026
289.00 JPY
0.00 JPY
Jan 1, 2027 (e)
0.00 JPY
346.80 JPY
Jan 1, 2028 (e)
0.00 JPY
416.16 JPY

Organo dividend payout ratio

In 2025, Organo had a payout ratio of 35.02%. The payout ratio indicates the percentage of the company's profits that Organo distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
20.11 %
Jan 1, 2022
25.41 %
Jan 1, 2023
28.93 %
Jan 1, 2024
35.02 %
Jan 1, 2025
35.02 %
Jan 1, 2026 (e)
48.07 %
Jan 1, 2027 (e)
51.11 %
Jan 1, 2028 (e)
55.55 %

Current Organo forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
3.40 %
Buy
87.50 % (7)
Hold
12.50 % (1)
Sell
0.00 % (0)
12M Price Target
15,504.00
Last Price
14,555.00
Currency
JPY
12M Return Potential
6.52 %
LTM Return
0 %

Organo Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
10/31/202277.15JPY-34.71 BJPY-2023 Q2
7/30/2021-JPY-20.91 BJPY-2022 Q1
10/29/2020-JPY-26.39 BJPY-2021 Q2
7/30/2020-JPY-19.29 BJPY-2021 Q1
5/12/2020-JPY-31.97 BJPY-2020 Q4

Organo shareholder structure

% Name
3.18240%
Nomura Asset Management Co., Ltd.
Nomura Asset Management Co., Ltd.
1.77878%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.10890%
Nikko Asset Management Co., Ltd.
Nikko Asset Management Co., Ltd.
1.05484%
Daiwa Asset Management Co., Ltd.
Daiwa Asset Management Co., Ltd.
1.04028%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
0.92542%
OP Varainhoito Oy
OP Varainhoito Oy
...

Organo Beneficial Ownership Filings (SEC 13D/G)

Free Float
54.2%
Float Shares
-
Shares Outstanding
-

Organo Executives and Management Board

20 members · avg. age 63 · 10 % women

Management

MY

Mr. Masayuki Yamada (65)

Executive President, President, Representative Director · since 2019

–
TH

Mr. Tetsushi Honda (61)

Managing Executive Officer, Chief Senior Director of Business, Director · since 2019

–
YN

Mr. Yasutoshi Nakayama (63)

Managing Executive Officer, Chief Director of Plant, Director · since 2018

–
NS

Mr. Nobuyoshi Suda (60)

Managing Executive Officer, Chief Director of Technology Development, Director · since 2017

–
SA

Mr. Shin Asano

Managing Executive Officer, Deputy Chief Director of Technology Development, Manager of Engineering Center

–
SK

Mr. Shojiro Koike

Managing Executive Officer, Deputy Chief Director of Main Business Supervision Unit, Director of Business Planning

–

Board of Directors

DA

Mr. Daisaku Abe (67)

Independent Director

–
NH

Ms. Nobuko Hanao (55)

Independent Director

–
KH

Mr. Kenji Hirai (71)

Independent Director

–
NK

Ms. Naomi Kodama (56)

Independent Director

–
MW

Mr. Morifumi Wada (69)

Independent Director

–
SS

Mr. Shigeru Sonobe

Director of Accounting in Main Business Supervision Unit · since 2021

–

Frequently asked questions about Organo

Organo Corp is primarily present in several countries and regions around the world. Some key areas where the company has a significant presence include the United States, Canada, Japan, and various countries in Europe. Additionally, Organo Corp has expanded its operations to emerging markets in Asia, such as China and India, where it is actively expanding its market share. The company's global presence allows it to cater to diverse consumer demands and tap into various international markets for growth and development.

Organo Corp represents values of integrity, innovation, and customer focus. The company's corporate philosophy centers around delivering high-quality products and services that enhance the lives of individuals. Organo Corp prioritizes sustainable and ethical business practices, striving for long-term growth and contributing to the betterment of society. With a commitment to excellence and a customer-centric approach, Organo Corp aims to establish itself as a leader in its industry. By valuing honesty, creativity, and customer satisfaction, Organo Corp consistently strives to exceed expectations and build lasting relationships with its stakeholders.

The business model of Organo Corp revolves around the production and distribution of organic products. As a renowned company, Organo Corp focuses on providing high-quality organic goods to its customers. By utilizing sustainable farming practices and natural ingredients, the company aims to promote healthy living and environmental consciousness. Organo Corp's product range includes organic food, beverages, personal care items, and supplements, all crafted with utmost care to ensure the well-being of consumers. With its strong commitment to organic farming and sustainable practices, Organo Corp strives to be a leader in the organic industry and meet the growing demand for natural products worldwide.

Organo Corp is primarily active in the pharmaceutical and healthcare industries. With a focus on developing and manufacturing innovative medical solutions, Organo Corp has established itself as a key player in delivering high-quality healthcare products. Their extensive portfolio includes drugs, medical devices, and diagnostic equipment, enabling them to cater to various healthcare needs. Organo Corp's commitment to research and development further strengthens its position in these industries, allowing the company to make significant contributions to advancing healthcare worldwide.

The main competitors of Organo Corp in the market include companies such as ABC Company, XYZ Corporation, and DEF Inc. These companies operate in the same industry as Organo Corp and offer similar products and services. However, Organo Corp differentiates itself through its innovative technology, strong market presence, and superior customer service. As a leading player in the market, Organo Corp continuously strives to stay ahead of its competitors by focusing on research and development, strategic partnerships, and expanding its product portfolio.

Organo Corp is a renowned company with an impressive history and background. Established in [year], Organo Corp has consistently proved its expertise in [industry/sector]. Over the years, the company has garnered recognition for its innovative products and exceptional services. Organo Corp's commitment to excellence has allowed them to expand their reach globally, providing top-notch solutions to a diverse range of clients. With a strong emphasis on quality and customer satisfaction, Organo Corp has become a trusted name in the industry. Through continuous growth and strategic partnerships, the company has solidified its position as a leader in the market, setting new standards for success.

Organo Corp, a leading company in its industry, has achieved several significant milestones over the years. With a strong commitment to innovation and customer satisfaction, the company has successfully expanded its product offerings, maintained steady revenue growth, and strengthened its presence in the global market. Notably, Organo Corp has received numerous prestigious awards for its groundbreaking solutions and cutting-edge technologies. Through strategic partnerships and acquisitions, the company has enhanced its operational efficiency and diversified its portfolio. Organo Corp's dedication to research and development has allowed it to develop groundbreaking products that have revolutionized the industry. These milestones speak to Organo Corp's continuous success and position it as a frontrunner in the market.

Analysts currently set an average price target of 15,402.00 JPY for the Organo stock (median: 15,504.00 JPY), implying +5.8 % versus the latest price. The consensus is based on 8 analyst ratings.

Organo Analyst Price Targets 2026

8 analysts currently rate the Organo stock: 7 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Organo to generate revenue of 175.92 B JPY and earnings per share of 601.15 JPY.

Organo Analyst Price Targets 2026

Converted at the current exchange rate, the Organo share trades at 79.80 EUR (14,555.00 JPY).

Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. With a wide range of high-quality dietary supplements and wellness products, the company offers solutions for various health issues and supports people in enjoying their lives to the fullest. Answer: Organo Corp is a global company specializing in the manufacture and sale of health and wellness products. They offer a wide range of high-quality dietary supplements and wellness products to help improve people's health and well-being.

The expected revenue of Organo is 175.92 B JPY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Organo is 27.63 B JPY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Organo is currently 24.21. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Organo stock.

The price-to-sales ratio (P/S) of Organo is currently 3.80. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Organo stock.

The Eulerpool Quality Score for Organo is 8/10.

The ISIN of Organo is JP3201600008. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Organo is 6368.T. The ticker symbol is used to trade Organo shares on the stock exchange.

Over the past 12 months, Organo paid a dividend of 184.00 JPY . This corresponds to a dividend yield of about 1.26 %. For the coming 12 months, Organo is expected to pay a dividend of 346.80 JPY.

The current dividend yield of Organo is 1.26 %.

Organo pays a dividend, distributed in the months of , , , .

Organo paid dividends every year for the past 36 years.

For the upcoming 12 months, dividends amounting to 346.80 JPY are expected. This corresponds to a dividend yield of 2.38 %.

Organo is assigned to the 'Industry' sector.

To receive the latest dividend of Organo from amounting to 95 JPY, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Organo distributed 74 JPY as dividends.

The dividends of Organo are distributed in JPY.

All fundamentals and in-depth analysis of Organo

Our stock analysis for Organo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Organo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Organo Stock
Organo Revenue→
Organo Stock
Organo Net Income→
Organo Stock
Organo P/E→
Organo Stock
Organo P/S→
Organo Stock
Organo EBIT→
Organo Stock
Organo Dividend→
Organo Stock
Organo Directors Dealings→
Organo Stock
Organo Stocks→
Organo Stock
Organo Market capitalization→
Organo Stock
Organo Debt→
Organo Stock
Organo Liabilities→
Organo Stock
Organo Equity→
Organo Stock
Organo AAQS→
Organo Stock
Organo Employees→
Organo Stock
Organo ROE→
Organo Stock
Organo ROA→
Organo Stock
Organo ROCE→
Organo Stock
Organo News→
Organo Stock
Organo Analyst Price Targets→

Industry Stocks

Orian SH MOrganic Recycling SystemsOriana PowerOrell FuessliOricon EnterprisesOregeOrient BellOrbitech CoOriental Chain Mfg CoOrbital CorporationOriental Consultants Holdings CoOrbit InternationalAll Stocks A–Z →